Latest Payments News

Argent BioPharma secured a 48% stake in CannPal Animal Therapeutics, shipped its largest CannEpil® order to Ireland worth A$783,000, and filed a US provisional patent for its NanoBodies platform, underpinning its neuro-immune strategy and commercial growth.

Nimy Resources has identified significant extensions to its high-grade gallium deposit at Mons Block 3 and shipped test material to the US as part of a strategic partnership. A scoping study is underway to evaluate mining and processing economics, while regional exploration continues across multiple targets.

Thor Energy secured A$6.56 million from the Molyhil sale, expanded its natural hydrogen portfolio with new Otway Basin licences, and advanced its HY-Range Project geochemistry survey during Q1 2026.

Volt Resources has secured a major extension and volume increase to its Bunyu graphite offtake agreement while progressing high purity graphite production and downstream refinery development in the US.

GCM Corporation finalises exclusive rights to its Very High Density technology, launches its first commercial heat sink products, and expands global prototyping efforts targeting high-growth sectors including EV infrastructure and data centres.

Pilbara Gold (ASX: PGL) reported a 50% jump in its Mt York gold resource to 2.08 million ounces following 27,000m of drilling in 2025, backed by a $30.5 million cash pile and a 50,000m drilling campaign underway in 2026.

Kalgoorlie Gold Mining has confirmed gold mineralisation extending to 300 metres depth at its Pinjin Gold Project, triggering its most ambitious drilling campaign to date, including extensive RC, diamond, and aircore programs.

Botanix Pharmaceuticals reported a 5% rise in Sofdra prescriptions in Q3 FY26 despite a dip in net revenue due to insurance deductible resets, strengthened by a $45 million capital raise and a new API supply deal with Piramal.

Omega Oil and Gas has secured a commanding acreage position in Queensland’s Taroom Trough and fully funded an expanded drilling program to accelerate appraisal and early production.

Sky Metals has bolstered its cash reserves with a $20.5 million raise, backing a major drilling push at Tallebung and expanding exploration at Doradilla, positioning both projects for significant resource growth and development progress.

Avecho Biotechnology has exceeded its Phase III CBD insomnia trial recruitment target by 16%, setting the stage for a more robust interim analysis scheduled for June 2026. The company’s commercial partnership with Sandoz AG and strengthened patent portfolio underpin its Australian market strategy.

Nova Eye Medical reported a 23% rise in quarterly sales to US$5.8 million, driven by strong US growth and initial Chinese sales. EBITDA loss narrowed significantly, with positive operational EBITDA recorded.